A large-scale study conducted across 19 universities and hospitals in Thailand, along with the Ministry of Public Health, found that medical-grade cannabidiol (CBD)-enriched oil significantly reduced seizures in children with drug-resistant epilepsy, with most patients tolerating the treatment for over a year. The prospective observational study followed 101 pediatric patients between 2021 and 2023. Participants …
Category: Studies
Study: Cannabis-Based Treatments Associated With Seizure Freedom in Drug-Resistant Epilepsy Patients
A new case series published in the journal Frontiers in Neuroscience details how cannabis-based products led to seizure freedom in nearly a dozen pediatric and adult patients with drug-resistant epilepsy (DRE). Conducted by researchers at the University of Toronto and University Health Network, the retrospective study evaluated 19 patients with DRE—15 of them children—who experienced …
Study: Combination of CBD and Hydroxychloroquine Found Safe and Bioavailable in Phase I Trial
A phase I clinical trial has found that a novel combination of cannabidiol (CBD) and hydroxychloroquine (HCQ), known as IHL-675 A, is well tolerated and bioavailable in healthy volunteers, supporting further investigation in inflammatory conditions such as rheumatoid arthritis. The trial involved 36 participants who were randomly assigned to receive either IHL-675 A, Epidiolex (CBD), …
Study: Aesthetic Elements of Psychedelic Experiences Strongly Linked to Psychological Benefits
A new study finds that the aesthetic quality of psychedelic experiences—such as vivid visual imagery and emotional beauty—may be a key factor in promoting therapeutic benefits. Researchers at the University of Colorado surveyed 96 individuals who had used classic psychedelics like psilocybin, LSD, DMT, or mescaline within the past year. Participants completed several psychological assessments, …
Study: Strong Majority of Psychiatric Patients Open to Psilocybin Therapy, Including Non-Hallucinogenic Options
A majority of psychiatric patients support the idea of psilocybin therapy, with many showing a willingness to try non-hallucinogenic forms, according to new research published in the Journal of Psychoactive Drugs. The study, conducted by researchers at Wright State University, surveyed patients aged 18 to 65 at a community mental health center to assess their …
Study: CBD Reduces Seizures and Brain Damage in Post-Traumatic Epilepsy Model
A new study published in the Journal of Ethnopharmacology finds that cannabidiol (CBD) may offer protective and anticonvulsant effects in cases of post-traumatic epilepsy (PTE). Researchers from Hunan University of Medicine and Ningxia Medical University in China conducted the study using a rat model of PTE triggered by ferric chloride (FeCl₃), including genetically modified rats …
Study: Cannabis Extract Reduces Inflammation in Human Skin Cells More Effectively than CBD Alone
A standardized cannabis extract significantly reduces inflammation in human skin cells—more effectively than CBD alone—according to a new study published in Pharmaceuticals. Researchers from Università degli Studi di Milano in Italy and Linnea SA in Switzerland analyzed the effects of a Cannabis sativa extract (CSE) with 5% CBD and less than 0.2% THC on human …
Study: Young Adults in Washington State May Be “Maturing Out” of Frequent Cannabis Use Earlier Than Expected
A new study conducted at the University of Washington suggests that young adults in Washington State may be reducing their cannabis use earlier than in years past, despite increased legalization and availability. Analyzing data from 15,371 individuals ages 18 to 25 collected across a seven-year period, researchers found that cannabis use peaked at ages 21 …
Study: Psilocybin May Help People With Anorexia Process Buried Trauma and Enter Remission
Women with anorexia experienced a resurfacing of previously blocked traumatic memories during psilocybin-assisted therapy, leading to remission of their eating disorder symptoms, according to a new study published in the Journal of Eating Disorders. The pilot study involved 10 women diagnosed with anorexia nervosa or in partial remission. Each received a 25-mg dose of COMP360, …
New Study Reveals How Different Parts of the Marijuana Plant Control Cannabinoid and Terpene Production
A new study published in BMC Genomics explores how different parts of the marijuana plant influence the production of cannabinoids and terpenes, offering insight into the plant’s internal regulatory mechanisms. Through a comprehensive transcriptomic analysis of wild cannabis, researchers identified over 2,500 differentially expressed genes (DEGs) across leaf, stem, and root tissues. These findings point …
Sponsored
